Cargando…

IL-17 intensifies IFN-γ-induced NOS2 upregulation in RAW 264.7 cells by further activating STAT1 and NF-κB

Interleukin-17 (IL-17) is a signature cytokine of Th17 cells. Previous research has indicated that IL-17 plays a proinflammatory role by exacerbating interferon-γ (IFN-γ)-induced inflammation. However, prior to this study, it was not known whether inducible nitric oxide synthase (iNOS or NOS2), a si...

Descripción completa

Detalles Bibliográficos
Autores principales: GAO, QIYUE, LIU, YANG, WU, YAN, ZHAO, QIANG, WANG, LIJUN, GAO, SHANSHAN, WEN, WEN, ZHANG, WEIPING, GUO, NING, ZHOU, JUAN, YUAN, ZUYI
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716793/
https://www.ncbi.nlm.nih.gov/pubmed/26677135
http://dx.doi.org/10.3892/ijmm.2015.2433
_version_ 1782410590070767616
author GAO, QIYUE
LIU, YANG
WU, YAN
ZHAO, QIANG
WANG, LIJUN
GAO, SHANSHAN
WEN, WEN
ZHANG, WEIPING
GUO, NING
ZHOU, JUAN
YUAN, ZUYI
author_facet GAO, QIYUE
LIU, YANG
WU, YAN
ZHAO, QIANG
WANG, LIJUN
GAO, SHANSHAN
WEN, WEN
ZHANG, WEIPING
GUO, NING
ZHOU, JUAN
YUAN, ZUYI
author_sort GAO, QIYUE
collection PubMed
description Interleukin-17 (IL-17) is a signature cytokine of Th17 cells. Previous research has indicated that IL-17 plays a proinflammatory role by exacerbating interferon-γ (IFN-γ)-induced inflammation. However, prior to this study, it was not known whether inducible nitric oxide synthase (iNOS or NOS2), a signature molecule of inflammation, could be intensified by IL-17 when combined with IFN-γ. Thus, we explored the roles and underlying mechanisms of IL-17 and IFN-γ in the regulation of NOS2 expression in RAW 264.7 cells using qPCR, western blot analysis, colorimetric analysis, ChIP assay and statistical analysis. Although IL-17 alone did not induce NOS2 expression or nitric oxide (NO) production, as shown by western blot analysis and colorimetric analysis, it intensified IFN-γ-induced NOS2 upregulation and NO production in RAW 264.7 cells. The alteration of relevant transcription factors demonstrated that a combination of IFN-γ and IL-17 enhanced Tyr701-phosphorylated signal transducer and activator of transcription 1 [p-STAT1(Y701)] and nuclear factor-κB (NF-κB) activation, nuclear translocations and their binding to the NOS2 promoter, compared with IFN-γ alone, as illustrated by the results of the western blot analysis and ChIP assay. Also, using the corresponding inhibitors of STAT1 and NF-κB, we noted downregulation of the expression of NOS2 induced by IFN-γ alone or in combination with IL-17, respectively. In addition, IFN-γ increased phosphorylated (p-)p38 mitogen-activated protein kinase (MAPK), and accelerated the activation of the NF-κB pathway and the expression of NOS2, but phosphorylated extracellular signal-regulated kinase 1/2 (p-ERK1/2) was reduced by treatment with IFN-γ and IL-17. IL-17 intensified the activation of the NF-κB pathway and NOS2 upregulation induced by IFN-γ by increasing the phosphorylation of p38 MAPK and limiting the phosphorylation of ERK1/2. Taken together, these results suggest that IL-17 intensified IFN-γ-induced NOS2 upregulation and NO production by increasing the transcription activity of p-STAT1(Y701) and NF-κB in RAW 264.7 cells. Further activation of the NF-κB pathway induced by IL-17 relied on enhanced phosphorylation of p38 MAPK and decreased phosphorylation of ERK1/2. The mechanism suggested in this study provides novel information which may be used for anti-inflammatory therapy with IL-17.
format Online
Article
Text
id pubmed-4716793
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-47167932016-01-22 IL-17 intensifies IFN-γ-induced NOS2 upregulation in RAW 264.7 cells by further activating STAT1 and NF-κB GAO, QIYUE LIU, YANG WU, YAN ZHAO, QIANG WANG, LIJUN GAO, SHANSHAN WEN, WEN ZHANG, WEIPING GUO, NING ZHOU, JUAN YUAN, ZUYI Int J Mol Med Articles Interleukin-17 (IL-17) is a signature cytokine of Th17 cells. Previous research has indicated that IL-17 plays a proinflammatory role by exacerbating interferon-γ (IFN-γ)-induced inflammation. However, prior to this study, it was not known whether inducible nitric oxide synthase (iNOS or NOS2), a signature molecule of inflammation, could be intensified by IL-17 when combined with IFN-γ. Thus, we explored the roles and underlying mechanisms of IL-17 and IFN-γ in the regulation of NOS2 expression in RAW 264.7 cells using qPCR, western blot analysis, colorimetric analysis, ChIP assay and statistical analysis. Although IL-17 alone did not induce NOS2 expression or nitric oxide (NO) production, as shown by western blot analysis and colorimetric analysis, it intensified IFN-γ-induced NOS2 upregulation and NO production in RAW 264.7 cells. The alteration of relevant transcription factors demonstrated that a combination of IFN-γ and IL-17 enhanced Tyr701-phosphorylated signal transducer and activator of transcription 1 [p-STAT1(Y701)] and nuclear factor-κB (NF-κB) activation, nuclear translocations and their binding to the NOS2 promoter, compared with IFN-γ alone, as illustrated by the results of the western blot analysis and ChIP assay. Also, using the corresponding inhibitors of STAT1 and NF-κB, we noted downregulation of the expression of NOS2 induced by IFN-γ alone or in combination with IL-17, respectively. In addition, IFN-γ increased phosphorylated (p-)p38 mitogen-activated protein kinase (MAPK), and accelerated the activation of the NF-κB pathway and the expression of NOS2, but phosphorylated extracellular signal-regulated kinase 1/2 (p-ERK1/2) was reduced by treatment with IFN-γ and IL-17. IL-17 intensified the activation of the NF-κB pathway and NOS2 upregulation induced by IFN-γ by increasing the phosphorylation of p38 MAPK and limiting the phosphorylation of ERK1/2. Taken together, these results suggest that IL-17 intensified IFN-γ-induced NOS2 upregulation and NO production by increasing the transcription activity of p-STAT1(Y701) and NF-κB in RAW 264.7 cells. Further activation of the NF-κB pathway induced by IL-17 relied on enhanced phosphorylation of p38 MAPK and decreased phosphorylation of ERK1/2. The mechanism suggested in this study provides novel information which may be used for anti-inflammatory therapy with IL-17. D.A. Spandidos 2016-02 2015-12-11 /pmc/articles/PMC4716793/ /pubmed/26677135 http://dx.doi.org/10.3892/ijmm.2015.2433 Text en Copyright: © Gao et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
GAO, QIYUE
LIU, YANG
WU, YAN
ZHAO, QIANG
WANG, LIJUN
GAO, SHANSHAN
WEN, WEN
ZHANG, WEIPING
GUO, NING
ZHOU, JUAN
YUAN, ZUYI
IL-17 intensifies IFN-γ-induced NOS2 upregulation in RAW 264.7 cells by further activating STAT1 and NF-κB
title IL-17 intensifies IFN-γ-induced NOS2 upregulation in RAW 264.7 cells by further activating STAT1 and NF-κB
title_full IL-17 intensifies IFN-γ-induced NOS2 upregulation in RAW 264.7 cells by further activating STAT1 and NF-κB
title_fullStr IL-17 intensifies IFN-γ-induced NOS2 upregulation in RAW 264.7 cells by further activating STAT1 and NF-κB
title_full_unstemmed IL-17 intensifies IFN-γ-induced NOS2 upregulation in RAW 264.7 cells by further activating STAT1 and NF-κB
title_short IL-17 intensifies IFN-γ-induced NOS2 upregulation in RAW 264.7 cells by further activating STAT1 and NF-κB
title_sort il-17 intensifies ifn-γ-induced nos2 upregulation in raw 264.7 cells by further activating stat1 and nf-κb
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716793/
https://www.ncbi.nlm.nih.gov/pubmed/26677135
http://dx.doi.org/10.3892/ijmm.2015.2433
work_keys_str_mv AT gaoqiyue il17intensifiesifnginducednos2upregulationinraw2647cellsbyfurtheractivatingstat1andnfkb
AT liuyang il17intensifiesifnginducednos2upregulationinraw2647cellsbyfurtheractivatingstat1andnfkb
AT wuyan il17intensifiesifnginducednos2upregulationinraw2647cellsbyfurtheractivatingstat1andnfkb
AT zhaoqiang il17intensifiesifnginducednos2upregulationinraw2647cellsbyfurtheractivatingstat1andnfkb
AT wanglijun il17intensifiesifnginducednos2upregulationinraw2647cellsbyfurtheractivatingstat1andnfkb
AT gaoshanshan il17intensifiesifnginducednos2upregulationinraw2647cellsbyfurtheractivatingstat1andnfkb
AT wenwen il17intensifiesifnginducednos2upregulationinraw2647cellsbyfurtheractivatingstat1andnfkb
AT zhangweiping il17intensifiesifnginducednos2upregulationinraw2647cellsbyfurtheractivatingstat1andnfkb
AT guoning il17intensifiesifnginducednos2upregulationinraw2647cellsbyfurtheractivatingstat1andnfkb
AT zhoujuan il17intensifiesifnginducednos2upregulationinraw2647cellsbyfurtheractivatingstat1andnfkb
AT yuanzuyi il17intensifiesifnginducednos2upregulationinraw2647cellsbyfurtheractivatingstat1andnfkb